Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis.

IF 1.4 4区医学 Q3 HEALTH CARE SCIENCES & SERVICES

American Health and Drug Benefits Pub Date : 2020-05-01

Jennie H Best, Ibrahim Abbass, Lenore Tominna, William Reiss

引用次数: 0

本刊更多论文

类风湿关节炎患者皮下注射Tocilizumab的剂量调整。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Health and Drug Benefits Medicine-Health Policy

CiteScore

2.90

自引率

0.00%

发文量

期刊介绍： AHDB welcomes articles on clinical-, policy-, and business-related topics relevant to the integration of the forces in healthcare that affect the cost and quality of healthcare delivery, improve healthcare quality, and ultimately result in access to care, focusing on health organization structures and processes, health information, health policies, health and behavioral economics, as well as health technologies, products, and patient behaviors relevant to value-based quality of care.